https://www.selleckchem.com/pr....oducts/pifithrin-u.h
Transplantation from living donor nephrectomy (LDN) is the best treatment for end-stage renal disease, but observed decrease in donor renal function is a major concern. The aim of this study was to externally validate a predictive model to estimate 1-year postdonation eGFR and risk of chronic kidney disease (CKD) in living donors. All LDN performed at Necker Hospital from January 2006 to May 2018 were retrospectively included. Observed eGFR (using CKD-EPI formula) at 1-year post LDN was compared to the predicted eGFR calculated with
Like
Comment
Share
